Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HAUS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | HSPG2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | CCDC149 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | FAM134A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
mRNA | SLC39A13 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | CCDC172 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | CORO7-PAM16 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | PRLH | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
mRNA | NUP153 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | CDIPT | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |